NEW YORK, July 5 (GenomeWeb News) - Shares in Bruker BioSciences were up 6 percent, or $.32, at $5.61 in mid-afternoon trading after the company this morning said it closed its $135 million acquisition of Bruker Optics.
Registering provides access to this and other free content.
Already have an account?Login Now.
CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.
In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."
In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.
Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.